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Background: In hemodialysis patients, aortic valve stenosis (AS) occurs with increased frequency and could contribute to the excess 
cardiovascular mortality. However, little is known about progression of AS in hemodialysis patients.
Methods: The study population consisted of 30 hemodialysis patients with mild or moderate AS. They were followed up by echocardiography for 
a period of at least 6 months and compared to 30 non-hemodialysis patients with mild or moderate AS. Patients with decreased left ventricular 
function (ejection fraction <50%) at entry were excluded. Change in peak aortic valve pressure gradient (AVPG) was calculated by Doppler 
echocardiography. In addition, frozen aortic valve samples obtained from a different cohort of 20 AS patients with hemodialysis (n=8) and non-
hemodialysis (n=12), were stained immunohistochemically with antibodies against macrophages, T-cells and endothelial cells in microvessels.
Results: AS in 6 of 30 patients (20%) progressed to severe at follow-up in hemodialysis patients and 4 of 30 patients (13%) in non-hemodialysis 
patients. AVPG at follow-up was significantly increased compared with that at entry in both of hemodialysis (36+13 to 54+21 mmHg, P<0.001) and 
non-dialysis patients (39+6 to 50+15 mmHg, P<0.001). The rate of change in AVPG was more rapid in hemodialysis patients than non-hemodialysis 
patients (9.7+4.7 vs. 4.7+9.5 mmHg/year, P<0.05). Immunohistochemical stainings showed an accumulation of macrophages and T-cells and lots 
of microvessels in aortic valve tissues of hemodialysis patients.
Conclusions: Progression of AS is more rapid in hemodialysis patients. In hemodialysis patients, the lesion of aortic valve is an active inflammatoly 
process with macrophage and T-cell infiltration and neoangiogenesis. An active inflammatory process in the lesion of aortic valve may be one of the 
mechanisms of rapid progression of AS in hemodialysis patients.
